Answers are grounded in this paper and cite their sources.
In the Y1 mouse adrenal tumor cell line, the 3 beta-hydroxysteroid dehydrogenase isomerase enzyme (3 beta-HSD) which catalyzes the transformation of 3 beta-hydroxy-5-ene steroids to 3-keto-4-ene steroids is active. The effect of type beta 1 transforming growth factor (TGF beta 1), a potent modulator of adrenocortical differentiated functions, on the 3 beta-HSD enzyme was studied. Four isoforms of 3 beta-HSD yielding proteins of different mobility on SDS-PAGE were previously detected in the mouse; whereas only one form was present in the mouse adrenal, we detected two isoforms in the Y1 cells. An inhibition of the basal enzymatic activity was observed after TGF beta 1 treatment which was correlated with a decrease in 3 beta-HSD protein (both isoforms) and mRNA levels.
No takes yet. Share an insight, caveat, or question.
Cherradi et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: